anastrozole has been researched along with Puberty, Precocious in 19 studies
Puberty, Precocious: Development of SEXUAL MATURATION in boys and girls at a chronological age that is 2.5 standard deviations below the mean age at onset of PUBERTY in the population. This early maturation of the hypothalamic-pituitary-gonadal axis results in sexual precocity, elevated serum levels of GONADOTROPINS and GONADAL STEROID HORMONES such as ESTRADIOL and TESTOSTERONE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We report a long-term follow-up on the use of anastrozole in the treatment of peripheral precocious puberty (PP) in McCune-Albright syndrome (MAS)." | 7.78 | Partial benefit of anastrozole in the long-term treatment of precocious puberty in McCune-Albright syndrome. ( Alves, C; Silva, SF, 2012) |
| "McCune-Albright Syndrome (MAS) is a congenital endocrine disorder due to mosaic tissutal hyper-function." | 5.38 | Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to McCune-Albright Syndrome. ( Fiore, L; Lala, R; Matarazzo, P; Mussa, A; Tessaris, D; Tuli, G; Verna, F, 2012) |
| "No difference in vaginal bleeding (mean number of days per year) was noted." | 5.35 | The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome. ( Eugster, EA; Lowe, ES; Mieszczak, J; Plourde, P, 2008) |
| " The potent estrogen suppressive action and simple dosage regimen of anastrozole suggest it may be advantageous compared to other aromatase inhibitors such as testolactone or anti-estrogens." | 5.31 | Effective aromatase inhibition by anastrozole in a patient with gonadotropin-independent precocious puberty in McCune-Albright syndrome. ( Albers, N; Freiberg, C; Roth, C; Zappel, H, 2002) |
| "We report a long-term follow-up on the use of anastrozole in the treatment of peripheral precocious puberty (PP) in McCune-Albright syndrome (MAS)." | 3.78 | Partial benefit of anastrozole in the long-term treatment of precocious puberty in McCune-Albright syndrome. ( Alves, C; Silva, SF, 2012) |
| "Treatment of testotoxicosis with bicalutamide plus anastrozole resulted in slower growth rate." | 2.75 | Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT). ( Amrhein, J; Armstrong, J; De Luca, F; Kulshreshtha, B; Mauras, N; McCormick, K; Melezinkova, H; O'Brien, S; Reiter, EO, 2010) |
| "A phase II study in testotoxicosis is currently underway,exploring the combination of a highly selective anti-androgen, bicalutamide, and the potent aromatase inhibitor, anastrozole." | 2.43 | Testotoxicosis: current viewpoint. ( Norjavaara, E; Reiter, EO, 2005) |
| "Testotoxicosis is a rare disorder which presents as isosexual peripheral precocious puberty in males." | 1.42 | Testotoxicosis: Report of Two Cases, One with a Novel Mutation in LHCGR Gene. ( Büyükünal, C; Ceylaner, S; Ercan, O; Evliyaoğlu, O; Özcabı, B; Özcan, R; Tahmiscioğlu Bucak, F; Tüysüz, B, 2015) |
| "McCune-Albright Syndrome (MAS) is a congenital endocrine disorder due to mosaic tissutal hyper-function." | 1.38 | Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to McCune-Albright Syndrome. ( Fiore, L; Lala, R; Matarazzo, P; Mussa, A; Tessaris, D; Tuli, G; Verna, F, 2012) |
| "Testotoxicosis is a rare form of precocious puberty caused by a constitutively activating mutation in the luteinizing hormone receptor (LHR) gene." | 1.35 | Effectiveness of anastrozole and cyproterone acetate in two brothers with familial male precocious puberty. ( Eyssette-Guerreau, S; Le Merrer, M; Pinto, G; Polak, M; Sultan, A; Sultan, C, 2008) |
| "Anastrozole is a safe and tolerable drug especially used to suppress estrogen action." | 1.35 | Treatment of autonomous ovarian follicular cyst with long-term anastrozole therapy. ( Berberoglu, M; Bilir, P; Engiz, O; Ocal, G; Siklar, Z, 2009) |
| "No difference in vaginal bleeding (mean number of days per year) was noted." | 1.35 | The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome. ( Eugster, EA; Lowe, ES; Mieszczak, J; Plourde, P, 2008) |
| " The potent estrogen suppressive action and simple dosage regimen of anastrozole suggest it may be advantageous compared to other aromatase inhibitors such as testolactone or anti-estrogens." | 1.31 | Effective aromatase inhibition by anastrozole in a patient with gonadotropin-independent precocious puberty in McCune-Albright syndrome. ( Albers, N; Freiberg, C; Roth, C; Zappel, H, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (47.37) | 29.6817 |
| 2010's | 10 (52.63) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leschek, EW | 1 |
| Flor, AC | 1 |
| Bryant, JC | 1 |
| Jones, JV | 1 |
| Barnes, KM | 1 |
| Cutler, GB | 1 |
| Arya, VB | 1 |
| Davies, JH | 1 |
| Senniappan, S | 1 |
| Wood, D | 1 |
| Hakeem, V | 1 |
| Stoneham, S | 1 |
| Freeman, A | 1 |
| Dattani, M | 1 |
| Klein, KO | 1 |
| Papadimitriou, DT | 1 |
| Dermitzaki, E | 1 |
| Papagianni, M | 1 |
| Papaioannou, G | 1 |
| Papaevangelou, V | 1 |
| Papadimitriou, A | 1 |
| Özcabı, B | 1 |
| Tahmiscioğlu Bucak, F | 1 |
| Ceylaner, S | 1 |
| Özcan, R | 1 |
| Büyükünal, C | 1 |
| Ercan, O | 1 |
| Tüysüz, B | 1 |
| Evliyaoğlu, O | 1 |
| Eyssette-Guerreau, S | 1 |
| Pinto, G | 1 |
| Sultan, A | 1 |
| Le Merrer, M | 1 |
| Sultan, C | 1 |
| Polak, M | 1 |
| Engiz, O | 1 |
| Berberoglu, M | 1 |
| Siklar, Z | 1 |
| Bilir, P | 1 |
| Ocal, G | 1 |
| Mitre, N | 1 |
| Lteif, A | 1 |
| Lenz, AM | 1 |
| Shulman, D | 1 |
| Eugster, EA | 2 |
| Rahhal, S | 1 |
| Fuqua, JS | 1 |
| Pescovitz, OH | 2 |
| Lewis, KA | 1 |
| Reiter, EO | 2 |
| Mauras, N | 1 |
| McCormick, K | 1 |
| Kulshreshtha, B | 1 |
| Amrhein, J | 1 |
| De Luca, F | 1 |
| O'Brien, S | 1 |
| Armstrong, J | 1 |
| Melezinkova, H | 1 |
| Tessaris, D | 1 |
| Matarazzo, P | 1 |
| Mussa, A | 1 |
| Tuli, G | 1 |
| Verna, F | 1 |
| Fiore, L | 1 |
| Lala, R | 1 |
| Alves, C | 1 |
| Silva, SF | 1 |
| Roth, C | 1 |
| Freiberg, C | 1 |
| Zappel, H | 1 |
| Albers, N | 1 |
| Norjavaara, E | 1 |
| Nakagawa, Y | 1 |
| Ohzeki, T | 1 |
| Kreher, NC | 1 |
| Delameter, P | 1 |
| Tiulpakov, A | 1 |
| Hochberg, Z | 1 |
| Mieszczak, J | 1 |
| Lowe, ES | 1 |
| Plourde, P | 1 |
| Faglia, G | 1 |
| Arosio, M | 1 |
| Porretti, S | 1 |
3 reviews available for anastrozole and Puberty, Precocious
| Article | Year |
|---|---|
Is there a role for estrogen activity assays? Recombinant cell bioassay for estrogen: Development and applications.
Topics: Anastrozole; Aromatase Inhibitors; Biological Assay; Breast Neoplasms; Child; Estradiol; Female; Hum | 2015 |
Testotoxicosis: current viewpoint.
Topics: Anastrozole; Androgen Antagonists; Anilides; Aromatase Inhibitors; Body Height; Child; Clinical Tria | 2005 |
[Precocious puberty].
Topics: Anastrozole; Aromatase Inhibitors; Female; Fibrous Dysplasia, Polyostotic; Gonadotropins, Pituitary; | 2006 |
3 trials available for anastrozole and Puberty, Precocious
| Article | Year |
|---|---|
Effect of Antiandrogen, Aromatase Inhibitor, and Gonadotropin-releasing Hormone Analog on Adult Height in Familial Male Precocious Puberty.
Topics: Adult; Anastrozole; Androgen Antagonists; Aromatase Inhibitors; Body Height; Child; Child, Preschool | 2017 |
Anastrozole plus leuprorelin in early maturing girls with compromised growth: the "GAIL" study.
Topics: Anastrozole; Aromatase Inhibitors; Body Height; Bone Density; Case-Control Studies; Child; Female; F | 2016 |
Bicalutamide plus anastrozole for the treatment of gonadotropin-independent precocious puberty in boys with testotoxicosis: a phase II, open-label pilot study (BATT).
Topics: Anastrozole; Anilides; Bone Development; Child; Child, Preschool; Drug Therapy, Combination; Gonadot | 2010 |
13 other studies available for anastrozole and Puberty, Precocious
| Article | Year |
|---|---|
Idiopathic gonadotropin-independent precocious puberty - is regular surveillance required?
Topics: Anastrozole; Anilides; Antineoplastic Combined Chemotherapy Protocols; Brain; Child; Chorionic Gonad | 2019 |
Gonadotrophin-independent precocious puberty associated with later diagnosis of testicular embryonal carcinoma.
Topics: Adolescent; Anastrozole; Androgens; Antineoplastic Agents, Hormonal; Carcinoma, Embryonal; Child; Ch | 2014 |
Testotoxicosis: Report of Two Cases, One with a Novel Mutation in LHCGR Gene.
Topics: Anastrozole; Androgen Antagonists; Anilides; Aromatase Inhibitors; Cytochrome P-450 CYP3A Inhibitors | 2015 |
Effectiveness of anastrozole and cyproterone acetate in two brothers with familial male precocious puberty.
Topics: Anastrozole; Androgen Antagonists; Aromatase Inhibitors; Body Height; Child, Preschool; Cyproterone | 2008 |
Treatment of autonomous ovarian follicular cyst with long-term anastrozole therapy.
Topics: Anastrozole; Aromatase Inhibitors; Child; Female; Humans; Nitriles; Ovarian Cysts; Puberty, Precocio | 2009 |
Treatment of familial male-limited precocious puberty (testotoxicosis) with anastrozole and bicalutamide in a boy with a novel mutation in the luteinizing hormone receptor.
Topics: Anastrozole; Androgen Antagonists; Anilides; Aromatase Inhibitors; Body Height; Body Weight; Child D | 2009 |
Bicalutamide and third-generation aromatase inhibitors in testotoxicosis.
Topics: Anastrozole; Androgen Antagonists; Anilides; Aromatase Inhibitors; Child, Preschool; Humans; Letrozo | 2010 |
Combined treatment with bicalutamide and anastrozole in a young boy with peripheral precocious puberty due to McCune-Albright Syndrome.
Topics: Anastrozole; Androgen Antagonists; Anilides; Aromatase Inhibitors; Child Development; Child, Prescho | 2012 |
Partial benefit of anastrozole in the long-term treatment of precocious puberty in McCune-Albright syndrome.
Topics: Age Determination by Skeleton; Anastrozole; Aromatase Inhibitors; Cafe-au-Lait Spots; Child, Prescho | 2012 |
Effective aromatase inhibition by anastrozole in a patient with gonadotropin-independent precocious puberty in McCune-Albright syndrome.
Topics: Anastrozole; Aromatase Inhibitors; Child; Enzyme Inhibitors; Estrogen Antagonists; Female; Fibrous D | 2002 |
Treatment of familial male-limited precocious puberty with bicalutamide and anastrozole.
Topics: Anastrozole; Androgen Antagonists; Anilides; Aromatase Inhibitors; Child; Child, Preschool; Humans; | 2006 |
The aromatase inhibitor anastrozole is ineffective in the treatment of precocious puberty in girls with McCune-Albright syndrome.
Topics: Anastrozole; Aromatase Inhibitors; Child; Child, Preschool; Female; Fibrous Dysplasia, Polyostotic; | 2008 |
Delayed closure of epiphyseal cartilages induced by the aromatase inhibitor anastrozole. Would it help short children grow up?
Topics: Anastrozole; Aromatase Inhibitors; Body Height; Bone Development; Child, Preschool; Enzyme Inhibitor | 2000 |